Renee Gala | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

702 results for “Renee Gala”

Trials

View all 495 →

Active, not recruiting

Gala Early Feasibility Study of RheOx

21 participants · First posted Aug 15, 2018

Gala Treatment for Chronic Bronchitis in Canada

10 participants · First posted Dec 28, 2017

Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)

140 participants · First posted May 27, 2022

Drugs

View all 103 →

GALA (Xenome Ltd.)

KLS-GABA

Investigational

GALE-301

Organizations

View all 27 →

GALA THERAPEUTICS INC

United States

RENEE COSMETICS PRIVATE LIMITED

India

Reneo Pharmaceuticals

United States

News

View all 77 →

Jazz Pharmaceuticals Names Renee Gala as CEO in Strategic Leadership Transition

Jazz Pharmaceuticals Completes $820M Actio Biosciences Acquisition, Adding First-in-Class KCNT1 Epilepsy Candidate ABS-1230

Jazz Pharmaceuticals to Acquire Actio Biosciences for $820 Million, Securing First-in-Class KCNT1 Epilepsy Therapy ABS-1230

Page 1 of 71